Research ArticleExperimental Studies
Open Access
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI and OUTI KUITTINEN
Anticancer Research August 2024, 44 (8) 3255-3259; DOI: https://doi.org/10.21873/anticanres.17143
RIINA K. OLLIKAINEN
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
2Cancer Center, Oulu University Hospital, Oulu, Finland;
ANTTI SIPPOLA
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
TAINA TURPEENNIEMI-HUJANEN
2Cancer Center, Oulu University Hospital, Oulu, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
HANNE KUITUNEN
2Cancer Center, Oulu University Hospital, Oulu, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
KATJA PORVARI
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
KIRSI-MARIA HAAPASAARI
4Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland;
MILLA E.L. KUUSISTO
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
5Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland;
6Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland;
TUULA KLAAVUNIEMI
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
OUTI KUITTINEN
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
7Cancer Center, Kuopio University Hospital, Kuopio, Finland
In this issue
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI, OUTI KUITTINEN
Anticancer Research Aug 2024, 44 (8) 3255-3259; DOI: 10.21873/anticanres.17143
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI, OUTI KUITTINEN
Anticancer Research Aug 2024, 44 (8) 3255-3259; DOI: 10.21873/anticanres.17143
Jump to section
Related Articles
Cited By...
- No citing articles found.








